Efficacy and Safety of Tenofovir Alafenamide (TAF) and Tenofovir Disoproxil Fumarate (TDF) Followed by TAF in Chronic Hepatitis B Patients of East Asian Ethnicity Following 5 Years of Treatment

Through 5 years, rates of virologic suppression were high in East Asian patients treated with TAF or switched from TDF to TAF. TAF and TDF were well tolerated, with improved renal and bone safety observed in patients switching from TDF to TAF.

Authors

Institutions

Publication Details

Journal
Alimentary Pharmacology & Therapeutics
Published
2025-08-12
DOI
https://doi.org/10.1111/apt.70327
Citations
4
Primary Topic
Hepatitis B Virus Studies
Type
article
Field-Weighted Citation Impact
5.42

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Efficacy and Safety of Tenofovir Alafenamide (TAF) and Tenofovir Disoproxil Fumarate (TDF) Followed by TAF in Chronic Hepatitis B Patients of East Asian Ethnicity Following 5 Years of Treatment

Seng Gee Lim, Wan‐Long Chuang, Leland J. Yee, Mang Ma et al.
4 citations
Alimentary Pharmacology & Therapeutics
Hepatitis B Virus Studies
5.42
article

Efficacy and Safety of Tenofovir Alafenamide (TAF) and Tenofovir Disoproxil Fumarate (TDF) Followed by TAF in Chronic Hepatitis B Patients of East Asian Ethnicity Following 5 Years of Treatment

Seng Gee Lim, Wan‐Long Chuang, Leland J. Yee, Mang Ma, Frida Abramov, John F. Flaherty, Marı́a Buti, Scott Fung, Namiki Izumi, Calvin Q. Pan, S. Shalimar, Young‐Suk Lim, Grace Lai–Hung Wong, Edward Gane, Hongyuan Wang, Rajiv Mehta
article en
4 citations

Abstract

Through 5 years, rates of virologic suppression were high in East Asian patients treated with TAF or switched from TDF to TAF. TAF and TDF were well tolerated, with improved renal and bone safety observed in patients switching from TDF to TAF.

Alimentary Pharmacology & TherapeuticsVol. 63(1)
Ulsan College (KR), Kaohsiung Medical University (TW), University of Auckland (NZ), University of Alberta (CA), Chinese University of Hong Kong (HK), University of Toronto (CA), Asan Medical Center (KR), University of Ulsan (KR), NYU Langone Health (US), Surya Hospitals (IN), Vall d'Hebron Hospital Universitari (ES), Gilead Sciences (United States) (US), National University Hospital (SG), Musashino Red Cross Hospital (JP), Toronto Liver Centre (CA), Guangzhou Eighth People's Hospital (CN), New York University (US), All India Institute of Medical Sciences (IN), Guangzhou Medical University (CN)
Gilead Sciences
Openalex Percentile: Top 4%
Hepatitis B Virus Studies
5.42
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.